Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Floris J Pos

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
BMJ Open|May 7, 2026
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trialSian Cooper, Sophie Alexander, Dylan Breitkreutz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2023
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trialLisa De Cock, Cédric Draulans, Floris J Pos, et al.
European Urology Open Science|January 5, 2023
Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile CancerHielke M de Vries, Sarah R Ottenhof, Tynisha S Rafael, et al.
Magnetic Resonance in Medicine|July 4, 2017
Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T<sub>2</sub> mapping across multiple systemsPetra J van Houdt, Harsh K Agarwal, Laurens D van Buuren, et al.
European Urology|December 26, 2021
Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate CancerVeerle H Groen, Karin Haustermans, Floris J Pos, et al.
International Journal of Radiation Oncology, Biology, Physics|May 16, 2019
Multiparametric MRI Tumor Probability Model for the Detection of Locally Recurrent Prostate Cancer After Radiation Therapy: Pathologic Validation and Comparison With Manual Tumor DelineationsCatarina Dinis Fernandes, Rita Simões, Ghazaleh Ghobadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2025
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: 10-Year Outcomes of the FLAME TrialKarolína Menne Guricová, Cédric Draulans, Floris J Pos, et al.
Frontiers in Oncology|December 13, 2021
Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort StudyMarie-Christina Jahreiß, Wilma D Heemsbergen, Bo van Santvoort, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 3, 2024
Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trialCédric Draulans, Karin Haustermans, Floris J Pos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 17, 2018
Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trialEvelyn M Monninkhof, Juliette W L van Loon, Marco van Vulpen, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
BMJ Open|May 7, 2026
Dose dE-eScalaTion IN prostATe radIOtherapy usiNg an MR-Linac in 2 Fractions (DESTINATION 2): protocol for a randomised, phase II/R-IDEAL2b trialSian Cooper, Sophie Alexander, Dylan Breitkreutz, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 13, 2023
From once-weekly to semi-weekly whole prostate gland stereotactic radiotherapy with focal boosting: Primary endpoint analysis of the multicenter phase II hypo-FLAME 2.0 trialLisa De Cock, Cédric Draulans, Floris J Pos, et al.
European Urology Open Science|January 5, 2023
Patterns of Recurrence and Survival After Pelvic Treatment for Locally Advanced Penile CancerHielke M de Vries, Sarah R Ottenhof, Tynisha S Rafael, et al.
Magnetic Resonance in Medicine|July 4, 2017
Performance of a fast and high-resolution multi-echo spin-echo sequence for prostate T<sub>2</sub> mapping across multiple systemsPetra J van Houdt, Harsh K Agarwal, Laurens D van Buuren, et al.
European Urology|December 26, 2021
Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate CancerVeerle H Groen, Karin Haustermans, Floris J Pos, et al.
International Journal of Radiation Oncology, Biology, Physics|May 16, 2019
Multiparametric MRI Tumor Probability Model for the Detection of Locally Recurrent Prostate Cancer After Radiation Therapy: Pathologic Validation and Comparison With Manual Tumor DelineationsCatarina Dinis Fernandes, Rita Simões, Ghazaleh Ghobadi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2025
Focal Boost to the Intraprostatic Tumor in External Beam Radiotherapy for Patients With Localized Prostate Cancer: 10-Year Outcomes of the FLAME TrialKarolína Menne Guricová, Cédric Draulans, Floris J Pos, et al.
Frontiers in Oncology|December 13, 2021
Impact of Advanced Radiotherapy on Second Primary Cancer Risk in Prostate Cancer Survivors: A Nationwide Cohort StudyMarie-Christina Jahreiß, Wilma D Heemsbergen, Bo van Santvoort, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 3, 2024
Stereotactic body radiotherapy with a focal boost to the intraprostatic tumor for intermediate and high risk prostate cancer: 5-year efficacy and toxicity in the hypo-FLAME trialCédric Draulans, Karin Haustermans, Floris J Pos, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 17, 2018
Standard whole prostate gland radiotherapy with and without lesion boost in prostate cancer: Toxicity in the FLAME randomized controlled trialEvelyn M Monninkhof, Juliette W L van Loon, Marco van Vulpen, et al.
Pageof 9